ArticleCVIR endovascular2024
Viabahn stent graft for arterial injury management: safety, technical success, and long-term outcome.
Article in CVIR endovascular, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 13 citations in OpenAlex.
- VIABAHN stent grafts for traumatic arterial injury: A case series.Journal of vascular surgery cases and innovative techniques · 2026Article
- A bioabsorbable adhesive wrap for sutureless arterial repair: Initial development and preclinical testing in a rat model.The journal of trauma and acute care surgery · 2026Article
- Bailout renal artery stent grafting in open repair of suprarenal abdominal aortic aneurysm.Journal of vascular surgery cases and innovative techniques · 2025Article
- A case of emergency stent graft placement for subclavian artery injury during ventriculoperitoneal shunt placement.Radiology case reports · 2025Article
- Ruptured Infected Pseudoaneurysms of Bilateral Carotid Artery Treated with Viabahn Stent Graft: A Case Report.Interventional radiology (Higashimatsuyama-shi (Japan) · 2025Article
- Evaluation of VIABAHNInterventional radiology (Higashimatsuyama-shi (Japan) · 2025Article
- Covered stent salvage for iatrogenic vertebral artery injury in traumatic cervical spine injury: A case report and literature review.BioMedicine · 2025Article
- Viabahn endoprosthesis for femoropopliteal aneurysm repair: safety, success rates, and long-term patency.CVIR endovascular · 2024Article
- Inadvertent insertion of dialysis catheter into subclavian artery treated with a covered stent: A case report.Acute medicine & surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Viabahn stent graft has emerged as an integral tool for managing vascular diseases, but there is limited long-term data on its performance in emergency endovascular treatment. This study aimed to assess safety, technical success, and long-term efficacy of the Viabahn stent graft in emergency treatment of arterial injury.
methodsWe conducted a retrospective single tertiary centre analysis of patients who underwent Viabahn emergency arterial injury treatment between 2015 and 2020. Indication, intraoperative complications, technical and clinical success, and major adverse events at 30 days were evaluated. Secondary efficacy endpoints were the primary and secondary patency rates assessed by Kaplan-Meier analysis.
resultsForty patients (71 ± 13 years, 19 women) were analyzed. Indications for Viabahn emergency treatment were extravasation (65.0%), arterio-venous fistula (22.5%), pseudoaneurysm (10.0%), and arterio-ureteral fistula (2.5%). No intraoperative adverse events occurred, technical and clinical success rates were 100%. One acute stent graft occlusion occurred in the popliteal artery on day 9, resulting in a 30-day device-related major-adverse-event rate of 2.5%. Median follow-up was 402 days [IQR, 43-1093]. Primary patency rate was 97% (95% CI: 94-100) in year 1, and 92% (95% CI: 86-98) from years 2 to 6. One stent graft occlusion occurred in the external iliac artery at 18 months; successful revascularization resulted in secondary patency rates of 97% (95% CI: 94-100) from years 1 to 6.
conclusionUsing Viabahn stent graft in emergency arterial injury treatment had 100% technical and clinical success rates, a low 30-day major-adverse-event rate of 2.5%, and excellent long-term patency rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.